Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer

  • Karolina Boman1Email author,
  • Ulrika Segersten2,
  • Göran Ahlgren3,
  • Jakob Eberhard4,
  • Mathias Uhlén5, 6,
  • Karin Jirström1 and
  • Per-Uno Malmström2
BMC Urology201313:17

DOI: 10.1186/1471-2490-13-17

Received: 20 January 2013

Accepted: 26 March 2013

Published: 8 April 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
20 Jan 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Feb 2013 Reviewed Reviewer Report - David DeGraff
26 Feb 2013 Reviewed Reviewer Report - Dermot Leahy
5 Mar 2013 Author responded Author comments - Karolina Boman
Resubmission - Version 3
5 Mar 2013 Submitted Manuscript version 3
19 Mar 2013 Reviewed Reviewer Report - Dermot Leahy
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
26 Mar 2013 Editorially accepted
8 Apr 2013 Article published 10.1186/1471-2490-13-17

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Clinical Sciences, Division of Pathology, Lund University, Skåne University Hospital
(2)
Department of Surgical Sciences, Uppsala University
(3)
Department of Clinical Sciences, Division of Urological Cancers, Lund University, Skåne University Hospital
(4)
Department of Clinical Sciences, Division of Oncology, Lund University, Skåne University Hospital
(5)
Science for Life Laboratory and School of Biotechnology, AlbaNova University Center, Royal Institute of Technology
(6)
School of Biotechnology, AlbaNova University Center, Royal Institute of Technology

Advertisement